15 | Monoclonal AntibodiesIBA
11/2015
-
02/2002 |
9 | AntibodiesIBA
01/2018
-
08/2006 |
6 | AntigensIBA
05/2020
-
07/2008 |
5 | MesothelinIBA
01/2018
-
07/2005 |
4 | PeptidomimeticsIBA
03/2013
-
05/2007 |
3 | Lewis Y antigenIBA
01/2018
-
02/2008 |
3 | amatuximabIBA
01/2018
-
11/2011 |
3 | LigandsIBA
09/2017
-
03/2007 |
3 | Peptides (Polypeptides)IBA
12/2016
-
03/2007 |
3 | Therapeutic UsesIBA
01/2015
-
05/2004 |
3 | Radioisotopes (Radionuclides)IBA
11/2011
-
11/2007 |
2 | CollagenIBA
12/2016
-
02/2016 |
2 | IntegrinsIBA
10/2016
-
03/2013 |
2 | GlypicansIBA
06/2015
-
01/2015 |
2 | Photosensitizing Agents (Photosensitizers)IBA
01/2015
-
05/2014 |
2 | Immunoglobulin FragmentsIBA
01/2015
-
10/2013 |
2 | Cetuximab (Erbitux)FDA Link
05/2014
-
11/2007 |
2 | Paclitaxel (Taxol)FDA LinkGeneric
05/2012
-
08/2006 |
2 | Trastuzumab (Herceptin)FDA Link
03/2010
-
11/2007 |
2 | Immunoglobulin Fab FragmentsIBA
03/2010
-
02/2002 |
2 | Carcinoembryonic AntigenIBA
08/2008
-
07/2008 |
2 | DOTA-biotin (90Y-DOTA-biotin)IBA
07/2005
-
10/2002 |
1 | Carmustine (FIVB)FDA Link
05/2020 |
1 | Melphalan (Alkeran)FDA LinkGeneric
05/2020 |
1 | Cytarabine (Cytosar-U)FDA LinkGeneric
05/2020 |
1 | Etoposide (VP 16)FDA LinkGeneric
05/2020 |
1 | Daclizumab (Zenapax)FDA Link
05/2020 |
1 | Messenger RNA (mRNA)IBA
09/2017 |
1 | Chemokine ReceptorsIBA
09/2017 |
1 | ChemokinesIBA
09/2017 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
12/2016 |
1 | N-end cysteine peptide tumor-homing peptideIBA
10/2016 |
1 | Coloring Agents (Dyes)IBA
10/2016 |
1 | DisulfidesIBA
10/2016 |
1 | cyclic arginine-glycine-aspartic acid peptideIBA
10/2016 |
1 | Neuropilin-1IBA
10/2016 |
1 | GadoliniumIBA
02/2016 |
1 | gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
02/2016 |
1 | Drug CarriersIBA
06/2015 |
1 | phthalocyanineIBA
01/2015 |
1 | 130-nm albumin-bound paclitaxelIBA
01/2015 |
1 | Albumin-Bound PaclitaxelFDA Link
01/2015 |
1 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2014 |
1 | Cell Surface ReceptorsIBA
11/2014 |
1 | Panitumumab (Vectibix)FDA Link
05/2014 |
1 | Immunoglobulin G (IgG)IBA
04/2014 |
1 | Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2013 |
1 | Fluorescent Dyes (Fluorescent Probes)IBA
10/2013 |
1 | Biomarkers (Surrogate Marker)IBA
05/2012 |
1 | Bevacizumab (Avastin)FDA Link
05/2012 |
1 | Chelating AgentsIBA
11/2011 |
1 | Integrin alphaVbeta3IBA
01/2010 |
1 | Biological ProductsIBA
01/2010 |
1 | EDDA (NiEDDA)IBA
01/2010 |
1 | Indium-111IBA
07/2009 |
1 | Yttrium-90IBA
06/2009 |
1 | Fas Ligand Protein (Fas Ligand)IBA
08/2008 |
1 | VaccinesIBA
08/2008 |
1 | Neoplasm Antigens (Tumor Antigens)IBA
07/2008 |
1 | Mucin-1 (CA 15-3 Antigen)IBA
07/2008 |
1 | Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2008 |
1 | RadiopharmaceuticalsIBA
07/2008 |
1 | Combined Antibody TherapeuticsIBA
11/2007 |
1 | Epidermal Growth Factor (EGF)IBA
11/2007 |
1 | CY5.5 cyanine dyeIBA
11/2007 |
1 | AvidinIBA
03/2007 |
1 | Peptide Hydrolases (Proteases)FDA Link
03/2007 |
1 | RhodaminesIBA
03/2007 |
1 | LectinsIBA
03/2007 |
1 | Interleukin-2 Receptor alpha SubunitIBA
08/2006 |
1 | Immunotoxins (Immunotoxin)IBA
08/2006 |
1 | Proteins (Proteins, Gene)FDA Link
07/2005 |
1 | Single-Chain AntibodiesIBA
07/2005 |
1 | Glycoproteins (Glycoprotein)IBA
07/2005 |
1 | StreptavidinIBA
07/2005 |
1 | BismuthIBA
05/2004 |